Extension of Time to File SOU

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: CDI-DAYSYMS (see, http://uspto.report/TM/87975578/mark.png)
SERIAL NUMBER: 87975578

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Actelion Pharmaceuticals Ltd, having an address of
      Gewerbestrasse 16
      Allschwil, CH-4123
      Switzerland
Proposed: Actelion Pharmaceuticals Ltd, having an address of
      Gewerbestrasse 16
      Allschwil, CH-4123
      Switzerland
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/24/2017.

For International Class 009:
Current identification: Computer software for generating and analyzing patient-reported outcomes e-questionnaires specific to Clostridium Difficile Associated Diarrhea

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 016:
Current identification: Printed questionnaires, namely, patient-reported outcomes paper questionnaires specific to Clostridium Difficile Associated Diarrhea

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 045:
Current identification: Medical services

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fifth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

The applicant's current Attorney Information:
      Cheryl Foytlin      Johnson & Johnson

      ONE JOHNSON & JOHNSON PLAZA
      NEW BRUNSWICK, New Jersey 08933
      United States
      Phone: 732 524 2889
      Fax: 732 524 6341
      The docket/reference number is T41803US1
      Email: tmus@its.jnj.com


The applicant's proposed Attorney Information:
      Cheryl Foytlin      Johnson & Johnson

      ONE JOHNSON & JOHNSON PLAZA
      NEW BRUNSWICK, New Jersey 08933
      United States
      Phone: 732 524 2889
      Fax: 732 524 6341
      The docket/reference number is T41803US1
      Email: tmus@its.jnj.com


Correspondence Information (current):
      Cheryl Foytlin
      PRIMARY EMAIL FOR CORRESPONDENCE: tmus@its.jnj.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rpetrova@its.jnj.com

Correspondence Information (proposed):
      Cheryl Foytlin
      PRIMARY EMAIL FOR CORRESPONDENCE: tmus@its.jnj.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rpetrova@its.jnj.com; MKyriako@ITS.JNJ.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $375 will be submitted with the form, representing payment for 3 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /clfjnj/      Date Signed: 04/20/2020
Signatory's Name: CHERYL FOYTLIN
Signatory's Position: Attorney of Record, NY Bar

Mailing Address:
   Johnson & Johnson
   
   ONE JOHNSON & JOHNSON PLAZA
   NEW BRUNSWICK, New Jersey 08933

RAM Sale Number: 87975578
RAM Accounting Date: 04/20/2020

Serial Number: 87975578
Internet Transmission Date: Mon Apr 20 13:21:11 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.X-20200420132111668
004-87975578-710776440e4886559616ad7761b
aad443b92525047018cc84738f51ffb489886-DA
-21117881-20200420123825259018